Last Price
Where today's price sits in its 52-week range
Pharma Aids Limited ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি মোটামুটি অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 45)। কোম্পানিটি লাভজনক। একই ধরনের অন্যান্য কোম্পানির তুলনায় শেয়ারটির দাম মোটামুটি স্বাভাবিক পর্যায়ে আছে। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 0.5%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Wait & Watch
Watch listAverage company, very little trading
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks pricey right now — costs more than usual for what you get.
P/E Ratio
28.5
Price per ৳1 of yearly earnings
Dividend Yield
0.50%
Annual cash return on the price
P/B Ratio
4.2
Price per ৳1 of net assets
Trading at 28.5 — below its 5-year average of 39.5.
The raw figures behind the verdict — for the curious.
EPS
৳20.45
Earnings per share (latest year)
P/E Ratio
26.2
Price you pay per ৳1 of earnings
Dividend Yield
0.50%
Annual cash return on the price
Reserve & Surplus
৳40.1 Cr
Company's accumulated savings
Total Loan
৳0.96 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Profitable in 4 out of the last 5 years.
Earnings Per Share
Profit you earn per share
Each share earned ৳20.4 in the latest year.
Yearly Cash Dividend
% of face value
📢 New 30% dividend just declared — record 07 Dec 2025
Paid a dividend every year for 5 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Down 2.5% in the past week, lagging the overall market.
Past week
-2.5%
Price move over 7 days
Vs market
-3.2%
Ahead/behind the DSEX index
Trading volume
1.2×
vs its normal volume
Up days
3/7
Green days this week
52-week spot
57%
Position in 1-year range
Trades around ৳0.70 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
PHARMAID scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| PHARMAID | 45 | ৳582 | +0.4% | 28.5 | +0.5% | +14.8% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Good sign — big institutions raised their stake from 16.4% to 23.5% since Jun 2025. People close to the company are buying.
Owners (sponsors) hold 24% — modest skin in the game.
Recent news and announcements about this company.